As expected, the lactate-pretreatment group showed remarkably reduced numbers of tumor-infiltrating CD8+ T cells in comparison with the control group, while the proportions of other immune cell subsets remained relatively unchanged (Figure 1M-R, Figure S1A). The gene discussed is CD8A; the disease is neoplasm.